All stock lists
Jazz Pharmaceuticals plc (NASDAQ:JAZZ)
IE · Delayed Price · Currency is USD
Healthcare · Biotechnology
209.00-5.00 (-2.33%)
Insider Score
––Not scored
JAZZ Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
JAZZ analyst forecast
JAZZ analyst consensus
Moderate Buy12 ratings
Buy 12 Hold 0 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
JAZZ 12-month price target
$295.00+41.3% upsideaverage of 4 firms
$300.00High
$281.00Low
Best analysts covering JAZZ
- Morgan Stanley100%success rate · 6 calls
- Truist Securities100%success rate · 4 calls
- JP Morgan100%success rate · 4 calls
- Baird100%success rate · 3 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
JAZZ analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2026-10-21 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2026-10-08 |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-10-07 |
| — | UBS | Buy | — | — | Reiterated | 2026-09-11 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-09-10 |
| RBC Capital | — | $299.00 | +20.8% | — | 2026-08-28 | |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-08-26 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2026-08-26 |
| — | Needham | Buy | — | — | Reiterated | 2026-08-26 |
| Deutsche Bank | Buy | $300.00 | +15.3% | Reiterated | 2026-08-26 | |
| RBC Capital | — | $277.00 | +7.6% | — | 2026-08-26 | |
| Truist Financial | — | $281.00 | +9.3% | — | 2026-08-26 | |
| Canaccord Genuity | — | $300.00 | +15.3% | — | 2026-08-26 | |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2026-08-11 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-08-04 |
| — | Baird | Outperform | — | — | Reiterated | 2026-08-04 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2026-08-04 |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-08-04 |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-08-04 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-08-04 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2026-08-04 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2026-08-04 |
| — | Needham | Buy | — | — | Reiterated | 2026-08-04 |
| — | Needham | Buy | — | — | Reiterated | 2026-07-20 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-07-14 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-07-14 |
| — | Deutsche Bank | Buy | — | — | Reiterated | 2026-07-09 |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-07-07 |
| — | B of A Securities | Buy | — | — | Reiterated | 2026-06-10 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-05-27 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2026-05-22 |
| — | UBS | Buy | — | — | Upgraded | 2026-05-19 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-05-06 |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-05-06 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-05-06 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2026-05-06 |
| — | Needham | Buy | — | — | Reiterated | 2026-04-24 |
| — | Leerink Partners | Outperform | — | — | Reiterated | 2026-04-22 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-04-20 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2026-03-19 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2026-02-25 |
| — | B of A Securities | Buy | — | — | Reiterated | 2026-02-25 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-02-25 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2026-02-25 |
| — | Needham | Buy | — | — | Reiterated | 2026-01-12 |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-01-12 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2025-12-10 |
| — | UBS | Neutral | — | — | Downgraded | 2025-11-24 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2025-11-18 |
| — | Baird | Outperform | — | — | Reiterated | 2025-11-18 |
| — | B of A Securities | Buy | — | — | Reiterated | 2025-11-18 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2025-11-17 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2025-11-17 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2025-11-06 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2025-10-27 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2025-10-20 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2025-09-24 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2025-08-29 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2025-08-28 |
| — | Needham | Buy | — | — | Reiterated | 2025-08-28 |
JAZZ earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-24 | 6.52 | 6.64 | $1.17B | $1.20B |
| 2026-05-05 | 4.64 | 6.34 | $978.7M | $1.07B |
| 2026-08-03 | 6.18 | 5.71 | $1.11B | $1.21B |
| 2026-11-02 | 6.26 | 0.00 | $1.21B | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.